FDA rule requires drugmakers to report manufacturing disruptions six months in advance

A new final rule from the US FDA now requires all drug and biologic manufacturers to notify the agency electronically of a permanent discontinuance or an interruption in manufacturing six months in advance, or as soon as is practical, before the disruption causes a shortage.

Read more at http://www.in-pharmatechnologist.com/Regulatory-Safety/FDA-rule-requires-drugmakers-to-report-manufacturing-disruptions-six-months-in-advance